PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Containe...

FDA Drug Recall #D-0154-2020 — Class III — October 21, 2019

Recall Summary

Recall Number D-0154-2020
Classification Class III — Low risk
Date Initiated October 21, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Location West Columbia, SC
Product Type Drugs
Quantity 19,390 syringes

Product Description

PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.

Reason for Recall

Incorrect labeling: Incorrect or missing lot and/or exp date

Distribution Pattern

Nationwide in the U.S.

Lot / Code Information

Lots: SU9079A, SU9079B, Exp 4/5/2020

Other Recalls from Nephron Pharmaceuticals Corporation d...

Recall # Classification Product Date
D-0150-2020 Class II Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25... Oct 9, 2019
D-0148-2020 Class II PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl... Oct 9, 2019
D-0147-2020 Class II PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine H... Oct 9, 2019
D-0151-2020 Class II del Nido Cardioplegia Solution, 1000 mL, Single... Oct 9, 2019
D-0149-2020 Class II PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl... Oct 9, 2019

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.